Artificial intelligence
Artificial Intelligence (AI) is revolutionising the pharmaceutical industry
and 2022 will present a radical shift in the innovation paradigm of the
sector. It’s expected that
28% of companies will be using AI
in the next two years.
Pharmaceutical companies worldwide are already leveraging advanced ML
algorithms and AI-powered tools to streamline the discovery and potential
of new medication and therapies. AI is predicted to create more affordable
drugs and therapy alternatives in the years to come while drastically
reducing operational costs. Many pharma companies will also introduce AI in
the manufacturing process to increase productivity and improve efficiency.
Rise in E-pharmacies
During the pandemic, e-pharmacies became a crucial tool for making
life-saving drugs accessible across the globe. Much like telemedicine that
allows patients to connect with their doctors from the comfort of their
homes, the e-pharmacy industry has a number of advantages with convenience
being at the very top of that list.
Many of these electronic pharmacies remain at the forefront of providing
chronic and self-medication to patients. As a growing trend, it’s expected
that the rise of e-pharmacies will continue steadily, with the overall
number of households served expected to
exceed the $70 million mark by 2025.
Precision medicine
Precision or “personalised” medicine is produced depending on a patient’s
specific diagnosis. Essentially, a drug is customised for optimal patient
results.
In the past, these smaller specialised precision medication factories were
few and far between. The manufacturing of such drugs was expensive and in
short demand. However, as we progress into 2022, the need for customised
medications is expected to become a trend as more patients seek refined
treatments that meet their personal needs and often, beliefs. AI and other
modern technologies will support this trend, making the manufacturing of
such drugs easier and more affordable.
Clinical trials
Digitisation is not new to the life sciences
industry, however, its contribution towards clinical trials is expected to
become more significant this in 2022. From improving medication adherence
to using the Internet of Things (IoT) technologies to boost patient
well-being and leveraging critical data, clinical trials will make
noteworthy advancements in the months to follow.
Soon, modern technology such as digital pills will
increase the accuracy of monitoring and reporting and will allow doctors
and scientists to track patient progress remotely.
Research and development
The Covid-19 pandemic has created a buzz around
pharmacovigilance, with
Covid vaccine safety
causing much speculation. Pharmaceutical companies are now, more than ever,
ensuring that their research and development hits the intended target.
There’s a continuous effort to achieve greater efficiency, effectiveness,
and safety to meet the patients’ needs and expectations while also
maintaining the bottom line.
Additionally, thanks to the success of
mRNA technology in the Covid-19 vaccine, researchers are now studying new ways in which the tech can help cure
other prevalent diseases such as Alzheimer’s and Parkinson’s. The sky is
truly the limit for research and development in the pharma industry, and
2022 is set to be a year full of innovation and milestones.
Interested in a career in the innovative pharmaceutical sector?
Are you looking to take the next step in your pharmaceutical career? Our
life sciences recruitment department is ready to help you discover what you
are looking for in your next role.
Quanta can connect you to biopharmaceutical jobs, pharmacovigilance jobs,
and other life science job opportunities, with positions available across
the globe. Explore our
life sciences jobs
and find out where your next career move could take you.
.png?v=3198cce397b003645f9eaff56a7d5300)
.png?v=8944c6ad3215f3472dbca988b14f7c36)
.png?v=1c9e581a98c2e17f28cd9e753a4768fa)